Literature DB >> 18597495

Serum albumin is as efficient as paraxonase in the detoxication of paraoxon at toxicologically relevant concentrations.

Miguel A Sogorb1, Sara García-Argüelles, Victoria Carrera, Eugenio Vilanova.   

Abstract

Human serum albumin was able to hydrolyze the organophosphorus compounds paraoxon, chlorpyrifos-oxon, and diazoxon at toxicologically relevant concentrations. Human serum displayed two paraoxon hydrolyzing activities: the so-called paraoxonase, which is associated with the lipoprotein fraction and is calcium dependent and EDTA sensitive, and the activity associated with albumin, which is EDTA resistant and sensitive to fatty acids. Human serum albumin hydrolyzed these compounds with the same relative efficacy as lipoproteins (chlorpyrifos-oxon > diazoxon > paraoxon). The capability of detoxication of activity associated with human serum albumin was similar or even higher than paraoxonase associated with lipoproteins in the case of paraoxon at concentrations as low as those noted in an acute in vivo intoxication. However, paraoxonase activity associated with lipoprotein was more effective than paraoxonase activity associated with albumin at toxicologically relevant chlorpyrifos-oxon concentrations. These results explain why mice deficient in paraoxonase associated with lipoprotein are not more sensitive to paraoxon than wild animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18597495     DOI: 10.1021/tx800075x

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  11 in total

1.  Detection of adduct on tyrosine 411 of albumin in humans poisoned by dichlorvos.

Authors:  Bin Li; Ivan Ricordel; Lawrence M Schopfer; Frédéric Baud; Bruno Mégarbane; Florian Nachon; Patrick Masson; Oksana Lockridge
Journal:  Toxicol Sci       Date:  2010-04-15       Impact factor: 4.849

2.  Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.

Authors:  R Hunter Coombes; Edward C Meek; Mary Beth Dail; Howard W Chambers; Janice E Chambers
Journal:  Toxicol Lett       Date:  2014-08-02       Impact factor: 4.372

3.  Acetylcholinesterase inhibitors: pharmacology and toxicology.

Authors:  Mirjana B Colović; Danijela Z Krstić; Tamara D Lazarević-Pašti; Aleksandra M Bondžić; Vesna M Vasić
Journal:  Curr Neuropharmacol       Date:  2013-05       Impact factor: 7.363

4.  Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings.

Authors:  Patrick Masson; Daniel Rochu
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

5.  Genomic and phenotypic alterations of the neuronal-like cells derived from human embryonal carcinoma stem cells (NT2) caused by exposure to organophosphorus compounds paraoxon and mipafox.

Authors:  David Pamies; Miguel A Sogorb; Marco Fabbri; Laura Gribaldo; Angelo Collotta; Bibiana Scelfo; Eugenio Vilanova; Georgina Harris; Anna Bal-Price
Journal:  Int J Mol Sci       Date:  2014-01-09       Impact factor: 5.923

6.  Serum Albumin Binding and Esterase Activity: Mechanistic Interactions with Organophosphates.

Authors:  Nikolay V Goncharov; Daria A Belinskaia; Vladimir I Shmurak; Maxim A Terpilowski; Richard O Jenkins; Pavel V Avdonin
Journal:  Molecules       Date:  2017-07-18       Impact factor: 4.411

Review 7.  Nanomaterial-Enabled Sensors and Therapeutic Platforms for Reactive Organophosphates.

Authors:  Seok Ki Choi
Journal:  Nanomaterials (Basel)       Date:  2021-01-16       Impact factor: 5.076

8.  Serum Paraoxonase-1 Activity and the Risk of Prostate Cancer Recurrence in Patients Treated with Radiotherapy.

Authors:  Milosz Jasinski; Dorota Olszewska-Slonina
Journal:  Antioxidants (Basel)       Date:  2022-02-10

9.  In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.

Authors:  Leonid Gaidukov; Dganit Bar; Shiri Yacobson; Esmira Naftali; Olga Kaufman; Rinat Tabakman; Dan S Tawfik; Etgar Levy-Nissenbaum
Journal:  BMC Clin Pharmacol       Date:  2009-11-17

10.  Cholinesterase assay by an efficient fixed time endpoint method.

Authors:  Mónica Benabent; Eugenio Vilanova; Miguel Ángel Sogorb; Jorge Estévez
Journal:  MethodsX       Date:  2014-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.